Multidisciplinary Cutaneous Lymphoma


UH Seidman Cancer Center


Kevin D. Cooper, MD (216-346-9546)


Kord Honda, MD (216-903-8435)


Susan Stebal (216-844-3634)


216-844-8200, select 1

Conditions Treated

  • Cutaneous T-cell lymphomas
  • Cutaneous B-cell lymphomas
  • Sezary leukemia
  • Sezary syndrome
  • Mycosis fungoides
  • Pseudolymphoma
  • Lymphoproliferative diseases of the skin

Therapies and Services

  • Full spectrum of skin directed therapies, systemic therapies and radiation therapies

Distinguishing Features

  • These programs, developed collaboratively by the Department of Dermatology and UH Seidman Cancer Center, provide the type of cross-specialty care and care-path development that is required for the optimum patient benefit and efficient delivery of services for patients with high-risk cancers occurring in the skin.
  • Weekly tumor boards staffed by physicians of different specialties, nurses and program staff allow rapid decision making based on pathologic, clinical and lab data, and consensus diagnostic and management recommendations.
  • Cutaneous dermatologic oncology, radiation oncology, dermatopathology, surgical oncology and medical oncology are included.

About UH Cleveland Medical Center
At the core of University Hospitals’ $4 billion health system is UH Cleveland Medical Center, ranked among America’s best hospitals by U.S. News & World Report. UH Cleveland Medical Center is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women’s health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and genetics. Its main campus includes UH Rainbow Babies & Children’s Hospital, ranked among the top children’s hospitals in the nation; UH MacDonald Women’s Hospital, Ohio’s only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University.

July 2017